Full-Time
GTM Recruiter
Collate
11-50 employees
AI-driven documentation automation for life sciences
No salary listed
San Francisco, CA, USA
In Person
Five days on-site in San Francisco.
 People & HR (1) |
|---|
Get referred to Collate
See people who can refer or advise you
- 7+ years of full-cycle recruiting experience with proven high performance in GTM hiring (AE, CS, Implementation, Support) at a high-growth startup
- You've hired into ambiguity before and built the playbook as you went
- Strong instincts for evaluating sales talent beyond the resume: how someone runs a discovery call, handles objections, and closes matters more to you than pedigree
- Fluent with modern sourcing and pipeline tools (Juicebox, LinkedIn Recruiter, Lever or similar ATS, AI-sourcing tools)
- Own full-cycle recruiting for our GTM org — Sales, Customer Success, Implementation, and Support — from intake through close
- Build the GTM pipeline from scratch: leverage Juicebox, LinkedIn Recruiter, source strong applicants in Lever and utilize Claude to accelerate quickly
- Source candidates who can sell into a regulated, technical, relationship-driven industry — this isn't generic SaaS AE hiring, and the pipeline should reflect that
- Run a tight offer process: comp benchmarking, closing strategy, and competitive positioning against other well-funded AI companies chasing the same talent
- Build the reporting layer — pipeline health, funnel conversion, source effectiveness — so GTM hiring decisions are data-backed, not vibes-backed
- Deliver a compelling pitch about Collate's mission to candidates who've never thought about life sciences infra before, and get them to care
- Bonus: experience recruiting for regulated or technical-buyer industries (health tech, fintech, infra) where the sales cycle isn't pure top-of-funnel volume
Collate provides an AI-powered platform that automates the creation and management of documentation for drug development, medical devices, and diagnostics. It works by generating, organizing, and governing regulatory and quality documents while offering data discovery and governance tools to ensure high-quality data assets. It distinguishes itself by offering an end-to-end, life-sciences–focused solution that covers drug, device, and diagnostic workflows in one platform, reducing manual work and speeding up approvals. Its goal is to shorten development and regulatory timelines so researchers can focus on discovery and bring life-saving innovations to patients faster.
Company Size
11-50
Company Stage
Series B
Total Funding
$125M
Headquarters
San Francisco, California
Founded
2025
Get referred to Collate
See people who can refer or advise you
Simplify's Take
What believers are saying
- Collate raised $95M Series C at ~$1B valuation in May 2025.
- It serves ~50 customers including major pharma and device makers.
- Documents once taking seven months now complete in one month or less.
What critics are saying
- AI hallucinations in GxP docs cause regulatory rejection within 6–12 months.
- FDA/EMA tightening audit rules adds costly human layers, eroding time savings.
- SAP and Salesforce outcompete Collate in enterprise data governance by 2027.
What makes Collate unique
- Collate is GxP-compliant AI-native software for life sciences documentation.
- It maintains human-in-the-loop oversight for audits and patient safety.
- The platform delivers 50–90% time savings with over 90% accuracy.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Company Equity
Flexible Work Hours
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 28%1 year growth
↑ 28%2 year growth
↑ 0%Biotech startup Collate, founded by Surbhi Sarna, has secured a $30 million seed fund to automate paperwork in the life sciences industry using AI. The funding round was led by Redpoint, with participation from First Round, Conviction Partners, and YC, valuing Collate at over $100 million. Collate aims to streamline documentation for diagnostic, medical device, and drug development companies, enhancing R&D and reducing time to market. Co-founders Nate Smith and Jigish Patel bring additional expertise.
Y Combinator's Surbhi Sarna has raised $30 million for Collate, a startup aiming to automate the tedious parts of running a life sciences business using AI.